Medtech

Novellus develops highly selective medicines for functionally and genomically defined cancer patients.

Maryline worked exclusively on population health problems with tech startups to gain understanding of the region, build a network, and leverage a corporate background to build partnerships.

Individuals as well as medical facilities use Dozee to track patients’ vitals.

WeMed has been testing a robotic-assisted system that executes—like a doctor’s hands— minimal invasive vascular therapy procedures, CEO and founder Yang He says.

Jianjia has developed Arthrobot, a robot which can position, grind, and install prostheses, to aid doctors during joint replacement surgeries.

McCooey, Nasdaq’s head of global capital markets and Asia Pacific, discussed the current IPO trends in China as well as the potential of Southeast Asian unicorns.

CorNeat offers a few innovative solutions, including the CorNeat KPro, an artificial cornea, as well as the CorNeat EverPatch, an artificial connective tissue substitute.

Biofourmis uses AI and machine learning to deliver software-based, data-driven therapies that enable personalized predictive care.